article_metadata: Shuhan Zhao Hao Du Zhanjie Zhang Jinsong Yang You Zhou Guixiang Xiao Hui Ma Caini Lan Jinzi Liang Kunyu Yang Lu Wen
article_metadata: 10.1177/00368504251315075
article_metadata: Sci Prog
article_metadata: 2025 Jan-Mar;108(1):368504251315075.
article_metadata: ini-1 smarcb1 case report immunotherapy sinonasal carcinoma
article_metadata: CC BY-NC
article_metadata: https://pubmed.ncbi.nlm.nih.gov/39886754/
article_metadata: Immune Checkpoint Inhibitors / therapeutic use SMARCB1 Protein / deficiency SMARCB1 Protein / genetics
article_metadata: Immune Checkpoint Inhibitors / therapeutic use SMARCB1 Protein / deficiency SMARCB1 Protein / genetics Case Reports Adult Aged B7-H1 Antigen / antagonists & inhibitors Combined Modality Therapy Female Humans Immunotherapy / methods Male Middle Aged Paranasal Sinus Neoplasms / drug therapy Paranasal Sinus Neoplasms / genetics Paranasal Sinus Neoplasms / pathology Paranasal Sinus Neoplasms / therapy Prognosis Programmed Cell Death 1 Receptor / antagonists & inhibitors Treatment Outcome SMARCB1 Protein SMARCB1 protein, human Immune Checkpoint Inhibitors Programmed Cell Death 1 Receptor B7-H1 Antigen PDCD1 protein, human CD274 protein, human
article_metadata: PMC11783480
article_metadata: 39886754
article_metadata: SMARCB1/INI-1-Deficient sinonasal carcinoma demonstrates a poor prognosis but favorable clinical outcomes after PD-1/PD-L1 inhibitor therapy: A case series
article_metadata: 2025